» Articles » PMID: 34013069

Effect of Antioxidant, Malondialdehyde, Macro-mineral, and Trace Element Serum Concentrations in Bangladeshi Patients with Schizophrenia: A Case-control Study

Overview
Journal Health Sci Rep
Specialty General Medicine
Date 2021 May 20
PMID 34013069
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Schizophrenia (SCZ) is an incurable neuropsychiatric disorder generally described by impaired social behavior and altered recognition of reality. For the first time, this study explored serum levels of antioxidants (vitamin A, E, and C), malondialdehyde (MDA), macro-minerals (calcium, potassium, and sodium), and trace elements (zinc, iron, and selenium) in Bangladeshi patients with SCZ and thereby, discovering any pathophysiological correlation.

Methods: This case-controlled study evaluated 63 patients with SCZ as cases and 63 healthy individuals as controls. Vitamin A and E levels were defined by RP-HPLC. MDA and vitamin C levels were measured by using UV spectrophotometry, and macro and trace elements by atomic absorption spectroscopy.

Results: This study found significantly ( ≤ 0.05) elevated MDA levels and decreased levels of antioxidants-vitamin A, C, and E and significantly ( ≤ 0.05) diminished levels of macro and trace elements in cases in contrast to the controls. Serum levels of zinc (Zn), selenium (Se), iron (Fe), potassium (K), calcium (Ca), and sodium (Na) were determined to be 0.33 ± 0.008, 0.0252 ± 0.00060, 0.24 ± 0.01, 64.18 ± 2.72, 36.88 ± 2.56, and 2657.5 ± 53.32 mg/L, respectively, in cases, whereas 0.79 ± 0.03, 0.0650 ± 0.00355,0.78 ± 0.03, 168.01 ± 2.85, 86.43 ± 2.55, and 3200.8 ± 29.96 mg/L, respectively, were determined in controls. Pearson's correlation analysis revealed a negative correlation between Zn and Na, Zn and K, Zn and Ca, Zn and Fe, Zn and Se, Fe and Na, and Fe and Se in patients.

Conclusions: The findings connect that the pathogenesis of SCZ may have a correlation with altered levels of antioxidants, MDA, macro-minerals, and trace elements.

Citing Articles

Progress in the study of oxidative stress damage in patients with schizophrenia: challenges and opportunities.

Zhang K, Zou L, Cai Y Front Psychiatry. 2025; 16:1505397.

PMID: 40060748 PMC: 11885282. DOI: 10.3389/fpsyt.2025.1505397.


The role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation.

Peng Z, Jia Q, Mao J, Jiang S, Ma Q, Luo X Schizophrenia (Heidelb). 2025; 11(1):4.

PMID: 39799168 PMC: 11724852. DOI: 10.1038/s41537-025-00555-8.


Relevance of diet in schizophrenia: a review focusing on prenatal nutritional deficiency, obesity, oxidative stress and inflammation.

Rarinca V, Vasile A, Visternicu M, Burlui V, Halitchi G, Ciobica A Front Nutr. 2024; 11:1497569.

PMID: 39734678 PMC: 11673491. DOI: 10.3389/fnut.2024.1497569.


Altered trace elements, antioxidant vitamin C, and malondialdehyde levels are associated with the pathophysiology and development of pre-hepatic jaundice: A case-control study.

Dewan S, Das A, Ahmed Z, Khan S, Nasim R, Sarwar M SAGE Open Med. 2024; 12:20503121241291977.

PMID: 39429543 PMC: 11489948. DOI: 10.1177/20503121241291977.


Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers.

Zorkina Y, Ushakova V, Ochneva A, Tsurina A, Abramova O, Savenkova V Metabolites. 2024; 14(2).

PMID: 38392971 PMC: 10890164. DOI: 10.3390/metabo14020080.


References
1.
Arinola G, Idonije B, Akinlade K, Ihenyen O . Essential trace metals and heavy metals in newly diagnosed schizophrenic patients and those on anti-psychotic medication. J Res Med Sci. 2011; 15(5):245-9. PMC: 3082825. View

2.
Do K, Conus P, Cuenod M . Redox dysregulation and oxidative stress in schizophrenia: nutrigenetics as a challenge in psychiatric disease prevention. World Rev Nutr Diet. 2010; 101:131-153. DOI: 10.1159/000314518. View

3.
Uddin M, Hossain M, Rahman M, Uddin A, Bhuiyan M . Elemental Zinc Is Inversely Associated with C-Reactive Protein and Oxidative Stress in Chronic Liver Disease. Biol Trace Elem Res. 2017; 178(2):189-193. DOI: 10.1007/s12011-016-0919-5. View

4.
Gerlach M, Ben-Shachar D, Riederer P, Youdim M . Altered brain metabolism of iron as a cause of neurodegenerative diseases?. J Neurochem. 1994; 63(3):793-807. DOI: 10.1046/j.1471-4159.1994.63030793.x. View

5.
Gleadhill I, Smith T, Yium J . Hyponatremia in patients with schizophrenia. South Med J. 1982; 75(4):426-8. DOI: 10.1097/00007611-198204000-00012. View